B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

HTR1B

MOLECULAR TARGET

5-hydroxytryptamine receptor 1B

UniProt: P28564NCBI Gene: 2507532 compounds

HTR1B (5-hydroxytryptamine receptor 1B) is targeted by 32 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting HTR1B

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Sumatriptan3.5032
2Quipazine2.309
3Mianserin1.614
4Metergoline1.614
5Ergotamine1.393
6Pergolide1.393
7Pindolol1.393
8Yohimbine1.393
9Aripiprazole1.102
10Bufotenin1.102
11Dihydroergotamine1.102
12Dihydroergotamine1.102
13Lisuride1.102
14Mescaline Hallucinogenic alkaloid isolated from1.102
15Methysergide1.102
16Oxymetazoline1.102
17Fluoxetine0.691
18Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent0.691
19brl 155720.691
20Bromocriptine0.691
21Buspirone0.691
22Cabergoline0.691
23Cyproheptadine0.691
24Lysergic Acid Diethylamide Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is0.691
25Metoclopramide0.691
26Nortriptyline0.691
27Ondansetron0.691
28pirenperone0.691
29Pramipexole0.691
30Propranolol0.691
31Tamsulosin0.691
32Vortioxetine0.691

About HTR1B as a Drug Target

HTR1B (5-hydroxytryptamine receptor 1B) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 32 compounds with documented HTR1B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

HTR1B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.